C19orf12
Protein C19orf12
Also known as: CS012_HUMAN, DKFZP762D096, MGC10922, MPAN, NBIA4, SPG43
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NSK7
- Gene
- C19orf12
- Ensembl
- ENSG00000131943
- Chromosome
- 19
- Canonical length
- 141 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a small transmembrane protein. Mutations in this gene are a cause of neurodegeneration with brain iron accumulation-4 (NBIA4), but the specific function of the encoded protein is unknown. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
141 residues, UniProt reviewed canonical sequence.
>Q9NSK7|C19orf12
1 MTIMVEDIMK LLCSLSGERK MKAAVKHSGK GALVTGAMAF VGGLVGGPPG LAVGGAVGGL
61 LGAWMTSGQF KPVPQILMEL PPAEQQRLFN EAAAIIRHLE WTDAVQLTAL VMGSEALQQQ
121 LLAMLVNYVT KELRAEIQYD DLocalizationUniProt · AlphaFold · HPA
Whether an antibody against C19orf12 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 111 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 111 nTPM
- tongue: 98 nTPM
- liver: 64 nTPM
- skeletal muscle: 59 nTPM
- breast: 39 nTPM
- heart muscle: 29 nTPM
Single-cell type
- enterocytes: 160 nCPM
- adipocytes: 133 nCPM
- schwann cells: 95 nCPM
- hepatocytes: 86 nCPM
- adrenal medulla cells: 85 nCPM
- proximal tubule cells: 82 nCPM
Immune cell
- gdT-cell: 17 nTPM
- memory CD8 T-cell: 13 nTPM
- naive CD8 T-cell: 13 nTPM
- T-reg: 12 nTPM
- naive CD4 T-cell: 11 nTPM
- MAIT T-cell: 10 nTPM
Brain region
- cerebral cortex: 53 nTPM
- hypothalamus: 47 nTPM
- basal ganglia: 46 nTPM
- pons: 46 nTPM
- amygdala: 44 nTPM
- midbrain: 43 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about C19orf12.
Disease | AllUniProt
Conditions C19orf12 is implicated in, by any mechanism.
- Neurodegeneration with brain iron accumulation 4 (NBIA4) MIM:614298
- Spastic paraplegia 43, autosomal recessive (SPG43) MIM:615043
Disease | GeneticClinVar
33 pathogenic / likely-pathogenic of 342 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodegeneration with brain iron accumulation 4
- Hereditary spastic paraplegia 43
- Neurodegeneration with brain iron accumulation
- C19orf12-related disorder
- Autosomal dominant C19orf12-related disorders
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.06
- gnomAD pLI
- 0.34
- gnomAD missense Z
- 0.39
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein C19orf12
- C19orf12-like protein
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads C19orf12 as an antibody target. Whether an autoantibody or antibody against C19orf12 could matter depends on whether native C19orf12 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
C19orf12 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label C19orf12 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...